Target intelligence / Profile preview

Solute carrier family 25 member 1 pseudogene 1 (SLC25A1P1)

Target
SLC25A1P1
Molecular classification
Pseudogene, Non-coding RNA (if transcribed)
01

Overview

Solute carrier family 25 member 1 pseudogene 1 (SLC25A1P1) is a human genomic locus classified as a pseudogene. It is homologous to the functional gene SLC25A1, which encodes a mitochondrial citrate transporter, but SLC25A1P1 itself contains sequence disruptions that prevent functional protein translation. Like many pseudogenes, SLC25A1P1 may be transcribed, but there is currently no evidence of biological activity—either as a protein or regulatory non-coding RNA. Pseudogenes in general can sometimes influence gene expression via mechanisms such as acting as microRNA decoys, but this has not been observed or described for SLC25A1P1. SLC25A1P1 does not currently play a role in human disease, is not a therapeutic target, and has no known relationship to drugs, biomarkers, or clinical monitoring.

Other names
Solute carrier family 25 member 1 pseudogene 1SLC25A1P1
02

Mechanism of action

None applicable. No mechanism of drug action is relevant since it is not a validated or actionable target.

03

Biological functions

No confirmed protein-based biological function. If transcribed, pseudogenes sometimes have regulatory roles (e.g., competing for microRNA binding as decoys or producing non-coding RNAs), but there is no evidence for such a role specific to SLC25A1P1.Generally, pseudogenes may participate in gene regulation via non-coding RNA mechanisms, but individual evidence is lacking for SLC25A1P1.
04

Disease associations

None currently established. In general, some pseudogenes (for example PTENP1 or KRAS1P) have been associated with tumor suppressive or oncogenic regulatory functions, but there is no specific evidence for SLC25A1P1’s involvement.No direct implication in cancer, inflammation, or other disease processes is documented for SLC25A1P1.

Beyond the preview

Go deeper on Solute carrier family 25 member 1 pseudogene 1 (SLC25A1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 1 pseudogene 1 (SLC25A1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call